Items where Author is "Peyvandi, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 5.

Article

Mohammadi, S. and Gholamin, M. and Mohammadi, M. and Mansouri, A. and Mahmoodian, R. and Attari, S. and Kebriaei, S. M. and Zibaei, B. and Roshanaei, M. and Daneshvar, F. and Khandehro, M. and Khodadadegan, M. A. and Delshad, A. and Mohammadzadeh, F. and Peyvandi, M. and Ghayour-Mobarhan, M. and Tavallaie, S. and Boroumand-Noughabi, S. and Ferns, G. A. A. (2018) Down-regulation of CatSper 1 and CatSper 2 genes by lead and mercury. Environmental Toxicology and Pharmacology, 59. pp. 82-86.

Mirzaei, H. and Naseri, G. and Rezaee, R. and Mohammadi, M. and Banikazemi, Z. and Mirzaei, H. R. and Salehi, H. and Peyvandi, M. and Pawelek, J. M. and Sahebkar, A. (2016) Curcumin: A new candidate for melanoma therapy? International Journal of Cancer, 139 (8). pp. 1683-1695.

Salarinia, R. and Sahebkar, A. and Peyvandi, M. and Mirzaei, H. R. and Jaafari, M. R. and Riahi, M. M. and Ebrahimnejad, H. and Nahand, J. S. and Hadjati, J. and Asrami, M. O. and Fadaei, S. and Salehi, R. and Mirzaei, H. (2016) Epi-drugs and epi-mirs: Moving beyond current cancer therapies. Current Cancer Drug Targets, 16 (9). pp. 773-788.

Salarinia, R. and Sahebkar, A. and Peyvandi, M. and Mirzaei, H. R. and Jaafari, M. R. and Riahi, M. M. and Ebrahimnejad, H. and Nahand, J. S. and Hadjati, J. and Asrami, M. O. and Fadaei, S. and Salehi, R. and Mirzaei, H. (2016) Epi-drugs and epi-mirs: Moving beyond current cancer therapies. Current Cancer Drug Targets, 16 (9). pp. 773-788.

Salarinia, R. and Sahebkar, A. and Peyvandi, M. and Mirzaei, H. R. and Jaafari, M. R. and Riahi, M. M. and Ebrahimnejad, H. and Nahand, J. S. and Hadjati, J. and Asrami, M. O. and Fadaei, S. and Salehi, R. and Mirzaei, H. (2016) Epi-drugs and epi-mirs: Moving beyond current cancer therapies. Current Cancer Drug Targets, 16 (9). pp. 773-788.

This list was generated on Fri Sep 18 04:59:27 2020 EDT.